Research published in The Lancet medical journal Monday showed good early results for two vaccines in the U.K. and China. The U.K. vaccine, coming out of the University of Oxford, stimulated an immune system response that built up both antibodies and T-cells, a sign of a strong vaccine candidate. Now, researchers need to determine just how effective their vaccines could be. Meanwhile, Russia is touting its own research amid allegations it's hacking other groups working toward an immunization.
2 More Vaccines Show Promise As Global Race Grows Tense
New trials will start for a Chinese vaccine; another in the U.K. had good early results. They're two of more than 200 in development across the world.
AP
Posted: 7:24 p.m. EDT Jul 20, 2020
Man vaccinated 217 times against COVID shows no side effects
Researchers studied the man and determined he had more COVID antibodies but experienced no side effects from being hypervaccinated.
This is the last week you can order free COVID-19 tests
Each household is eligible for up to eight at-home COVID-19 tests, depending on when they last ordered.
CDC says seniors should get second COVID shot of 2023-24
Despite promising data, few Americans have gotten an updated COVID shot since the vaccines were released in September.
In interview, Trump says Jews who vote for Democrats 'hate Israel'
Former President Donald Trump, in an interview, had been asked about Democrats' growing criticism of Israeli Prime Minister Benjamin Netanyahu.
1:19
Lawmakers reach unofficial deal on government funding
Lawmakers have agreed on the key components of the bill, but the language will still need to be prepared ahead of a Friday funding deadline.
Former Tesla worker settles discrimination case after $3M verdict
This settles appeals both sides were pursuing after a federal jury awarded the former employee nearly $3.2 million last April.